Benign neoplasm: Cerebral meninges

CD2_BENIGN_MENINGES_CEREBRAL_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D32.0 Hospital discharge: ICD-9 — 2252 Hospital discharge: ICD-8 — 2252 Cause of death: ICD-10 — D32.0 Cause of death: ICD-9 — 2252 Cause of death: ICD-8 — 2252 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D32
Name in latin: Neoplasma benignum meningum cranialium

NAME	CD2_BENIGN_MENINGES_CEREBRAL_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D320
HD_ICD_9	2252
HD_ICD_8	2252
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D320
COD_ICD_9	2252
COD_ICD_8	2252
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Cerebral meninges based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Cerebral meninges

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3454	2625	829
Unadjusted period prevalence (%)	0.77	0.89	0.37
Median age at first event (years)	62.55	61.48	65.94

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3050: Matched controls
30501

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

+∞

323.0

507

H02AB02

ATC

dexamethasone; systemic

83.8

323.0

649

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

872.5

323.0

1222

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

348.8

323.0

393

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

4140.3

323.0

376

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

1667.6

323.0

846

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

+∞

323.0

1848

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

+∞

323.0

1041

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

27.7

323.0

1391

897

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

158.2

274.0

287

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

16.9

237.7

392

264

115

Kela drug reimbursment

Breast cancer

+∞

217.3

206

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

450.0

213.3

211

AA1AD

NOMESCO Finland

CT of head and brain

3.7

212.1

1257

4885

D32.06

ICD-10 Finland

Benign tumor of the meninges os petrosum or clivus area

+∞

199.1

189

N03AX14

ATC

levetiracetam; systemic

15.9

196.8

331

231

D32.05

ICD-10 Finland

Cerebral meninges

+∞

193.8

184

PJA12

NOMESCO Finland

Sentinel node biopsy

248.8

183.7

187

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

7.8

183.3

454

669

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.5

179.1

593

1285

WF002

NOMESCO Finland

Radical radiotherapy

374.5

178.4

178

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

265.0

172.4

175

D32.03

ICD-10 Finland

Benign meningioma in ventricles

1679.7

160.8

155

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.7

149.9

798

2697

130

Kela drug reimbursment

Malignant tumour

+∞

149.2

142

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

147.1

140

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

+∞

141.8

135

ZXC95

NOMESCO Finland

Use of surgical navigator

25.7

136.1

193

WX408

NOMESCO Finland

General anesthesy, balanced

3.0

134.0

1012

4363

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

12.5

129.5

241

208

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

+∞

129.1

123

A04AA02

ATC

granisetron; systemic, transdermal

175.0

128.5

134

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

128.0

122

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

122.7

117

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

114.9

122.0

132

2252A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Cerebral meninges

+∞

121.7

116

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

12.9

116.3

213

177

N03AF02

ATC

oxcarbazepine; oral

8.1

115.4

273

365

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

65.6

113.9

132

XX3DW

NOMESCO Finland

Time consuming IT work

5.9

108.7

327

611

WF003

NOMESCO Finland

Adjuvant radiotherapy

546.6

107.4

106

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

11.7

102.5

196

178

AA1BD

NOMESCO Finland

Extensive CT of head and brain

11.6

101.4

195

179

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

+∞

100.6

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

999.9

99.7

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

99.5

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.8

97.3

748

3151

L02BG04

ATC

letrozole; oral

25.1

96.3

137

C61

ICD-10 Finland

Malignant neoplasm of prostate

204.5

96.0

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

92.1

L02BA01

ATC

tamoxifen; oral

242.3

92.0

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

10.0

88.5

183

193

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

303.9

87.2

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

439.7

86.5

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

13.8

86.3

152

115

HAB40

NOMESCO Finland

Wedge excision of mammary gland

20.8

83.7

126

HAC20

NOMESCO Finland

Total mastectomy

101.8

81.3

XCK00

NOMESCO Finland

Perimetry

3.7

80.4

391

1173

9537/0-C70.0

ICD-O-3

Transitional meningioma of cerebral meninges

+∞

79.5

H53.4

ICD-10 Finland

Visual field defects

7.9

79.4

189

253

D32.1

ICD-10 Finland

Benign neoplasm: Spinal meninges

48.9

78.2

WX402

NOMESCO Finland

General anaesthesia

2.9

77.8

540

2098

9539/1-C70.0

ICD-O-3

Atypical meningioma of cerebral meninges

+∞

77.4

2152

FHL

Extraction, big brain

96.0

76.3

WX882

NOMESCO Finland

High dependency care

7.6

76.3

186

258

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

745.9

74.5

A03FA01

ATC

metoclopramide; systemic, rectal

2.8

74.2

555

2254

L03AA13

ATC

pegfilgrastim; parenteral

376.2

74.0

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

735.4

73.5

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

131.6

72.2

ZX090

NOMESCO Finland

Other technic of radiotherapy

249.1

71.6

ZX050

NOMESCO Finland

Stereotactic radiotherapy

355.1

69.9

R51.80

ICD-10 Finland

Headache

2.6

69.3

572

2454

C50.99

ICD-10 Finland

Breast, unspecified

693.4

69.3

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

105.3

66.1

ZXC40

NOMESCO Finland

Use of ultrasound

31.9

65.5

N03AB02

ATC

phenytoin; systemic

10.6

63.2

126

124

116

Kela drug reimbursment

Prostate cancer

+∞

62.7

G40.9

ICD-10 Finland

Epilepsy, unspecified

5.4

62.5

198

388

JN4BD

NOMESCO Finland

Extensive body CT

4.3

60.9

240

592

22520

ICD-8 Finland

Benign neoplasm of brain and other parts of nervous system, Cerebral meninges

+∞

60.6

WX110

NOMESCO Finland

Local anesthesy

1.9

60.5

2013

15387

9532/0-C70.0

ICD-O-3

Fibrous meningioma of cerebral meninges

+∞

58.5

A02BC02

ATC

pantoprazole; systemic

1.9

58.5

2052

15878

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.3

58.3

628

3073

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

107.2

58.0

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

9.2

57.7

124

140

D32

ICD-10 Finland

Benign neoplasm of meninges

297.4

57.4

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.1

57.1

870

4959

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

292.0

56.4

HA1AA

NOMESCO Finland

X-ray mammography

4.6

55.2

203

467

WF099

NOMESCO Finland

Other radiotherapy

102.0

55.0

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

53.3

L01BC06

ATC

capecitabine; oral

+∞

53.3

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

+∞

53.3

N02BE01

ATC

paracetamol; systemic, rectal

2.2

53.1

2662

23042

N03AF01

ATC

carbamazepine; oral, rectal

3.5

53.1

264

797

R4110

NOMESCO Finland

Physiotherapy

2.0

52.4

840

4856

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.2

52.3

211

531

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

112.0

50.9

D33.30

ICD-10 Finland

Acoustic neuroma

18.6

50.2

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

4.4

49.6

191

460

WF049

NOMESCO Finland

Radiotherapy of metastasis

495.6

49.5

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

80.1

49.0

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

485.2

48.5

XA800

NOMESCO Finland

Neuropsychological investigation

4.4

47.5

180

426

H47.2

ICD-10 Finland

Optic atrophy

23.1

47.1

S18

ICPC

Laceration/cut

1.8

46.9

1253

8593

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

464.5

46.4

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

45.9

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

45.9

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

20.4

45.3

AAK00

NOMESCO Finland

Cranioplasty

74.2

45.1

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.8

44.2

200

557

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

228.2

44.0

N76

ICPC

Neoplasm nervous system unspecified

97.5

43.9

A04AA55

ATC

palonosetron, combinations; systemic

+∞

43.8

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

9.3

43.4

102

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.5

43.0

158

363

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

9.9

42.6

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

41.8

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

41.8

SPAT1153

SPAT

Removal of sutures

1.8

40.9

985

6459

C50

ICD-10 Finland

Malignant neoplasm of breast

145.3

40.8

N75

ICPC

Benign neoplasm nervous system

145.3

40.8

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

11.1

40.1

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

10.5

40.0

D42.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cerebral meninges

89.3

39.9

X76

ICPC

Malignant neoplasm breast female

141.9

39.8

G40.10

ICD-10 Finland

Simple partial seizures

12.9

39.8

A04AA01

ATC

ondansetron; systemic, rectal

4.8

39.7

137

295

ABB00

NOMESCO Finland

Excision of lesion of spinal canal

23.7

39.3

C70.0

ICD-10 Finland

Malignant neoplasm: Cerebral meninges

+∞

38.6

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

38.6

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

38.6

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

38.6

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

38.6

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

51.8

38.6

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

13.7

38.5

H02AB09

ATC

hydrocortisone; systemic

5.8

38.4

112

199

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

37.0

425

2101

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

36.9

453

2305

NK6AN

NOMESCO Finland

Total body bone isotope imaging

36.7

36.9

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

36.7

1251

9010

L03AA02

ATC

filgrastim; parenteral

38.9

36.6

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

36.5

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

12.2

36.1

JN4AD

NOMESCO Finland

Body CT examination

3.9

36.0

156

419

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

81.1

35.9

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

35.5

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

+∞

35.5

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

59.3

35.2

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

5.7

35.0

104

189

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

182.0

34.8

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.3

34.8

350

1624

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

34.4

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

176.9

33.8

D33.02

ICD-10 Finland

Another benign medial tumor of the cerebrum

121.4

33.7

TAB00

NOMESCO Finland

Lumbar puncture

3.4

33.6

174

540

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

33.4

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

64.1

33.0

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

32.3

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

32.3

8000/0-C70.0

ICD-O-3

Neoplasm, benign of cerebral meninges

+∞

32.3

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

32.3

R42

ICD-10 Finland

Dizziness and giddiness

1.7

32.0

758

4872

ZX070

NOMESCO Finland

Intensity modified radiotherapy

320.2

31.9

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

5.4

31.4

185

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

31.4

302

1366

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

9.0

31.3

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

31.3

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

31.9

31.3

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

30.2

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

30.2

N03AG01

ATC

valproic acid; systemic, rectal

2.7

29.9

220

862

L02BG03

ATC

anastrozole; oral

83.4

29.8

ZX080

NOMESCO Finland

Image guided radiotherapy

156.5

29.7

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

57.2

29.1

CS494

NOMESCO Finland

Other visual field testing

4.0

28.9

120

311

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

28.8

281

1280

A04AD12

ATC

aprepitant; systemic

151.4

28.7

HAB99

NOMESCO Finland

Other partial excision of mammary gland

8.1

28.6

L02AE02

ATC

leuprorelin; implant, parenteral

9.7

28.4

H53.2

ICD-10 Finland

Diplopia

3.6

28.2

132

379

Y77

ICPC

Malignant neoplasm prostate

+∞

28.2

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

9.4

27.9

A79

ICPC

Malignancy NOS

78.4

27.8

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

27.4

574

3528

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.0

27.2

162

556

N03AX18

ATC

lacosamide; systemic

12.1

26.9

WX872

NOMESCO Finland

Intensive care

2.9

26.8

174

631

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

26.1

Z51.5

ICD-10 Finland

Palliative care

4.4

26.0

228

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

25.9

702

4643

WZC30

NOMESCO Finland

Teaching

2.2

25.9

283

1359

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

262.7

25.7

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

262.7

25.7

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

13.5

25.5

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

10.0

25.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

25.4

472

2784

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

50.4

25.2

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

25.0

B01AB05

ATC

enoxaparin; parenteral

1.6

24.4

818

5714

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

8.3

24.3

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

48.7

24.3

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

24.0

183

Kela drug reimbursment

Lamotrigin and topiramate

7.6

23.8

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

241.7

23.7

L03AA14

ATC

lipegfilgrastim; parenteral

241.7

23.7

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

126.0

23.6

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

18.6

23.0

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

22.9

128

Kela drug reimbursment

Cancers of female genital organs

+∞

22.9

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

22.9

ZXA05

NOMESCO Finland

Left side

1.6

22.9

756

5246

ZZR00

NOMESCO Finland

Flap of skin

10.1

22.8

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

231.6

22.6

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

231.6

22.6

L02BB03

ATC

bicalutamide; oral

231.6

22.6

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.5

22.6

183

757

H47.1

ICD-10 Finland

Papilloedema, unspecified

10.6

22.3

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

22.2

1006

7506

N05CF01

ATC

zopiclone; oral

1.5

22.2

969

7167

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

7.8

22.2

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.3

22.0

218

1000

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

21.9

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

21.9

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

21.9

9531/0-C70.9

ICD-O-3

Meningothelial meningioma of meninges, NOS

+∞

21.9

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

221.4

21.6

E23.00

ICD-10 Finland

Panhypopituitarism

12.8

21.6

WF004

NOMESCO Finland

Palliative radiotherapy

115.8

21.6

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

21.5

296

1563

101

Kela drug reimbursment

Anterior pituitary hypofunction

12.0

21.5

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

20.9

21.2

9530/0-C70.1

ICD-O-3

Meningioma, NOS, of spinal meninges

50.4

21.1

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

50.4

21.1

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.3

21.1

108

334

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

34.0

21.1

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

20.9

288

1521

B01AB10

ATC

tinzaparin; parenteral

2.6

20.9

152

592

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

20.8

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

20.8

ZZF00

NOMESCO Finland

Graft of adipose tissue

21.6

20.8

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

9.3

20.8

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

77.3

20.7

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

211.3

20.6

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

20.4

424

2576

XKD00

NOMESCO Finland

Uroflowmetry

1.9

20.4

303

1643

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

57.9

19.9

9539/1-C70.9

ICD-O-3

Atypical meningioma of meninges, NOS

+∞

19.8

N74

ICPC

Malignant neoplasm nervous system

+∞

19.8

L02BG06

ATC

exemestane; oral

+∞

19.8

UKC02

NOMESCO Finland

Cystoscopy

1.8

19.8

382

2269

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

73.9

19.7

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

105.7

19.6

ZXA00

NOMESCO Finland

Right side

1.5

19.4

783

5661

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

5.4

19.2

110

WX704

NOMESCO Finland

Intubation

2.2

19.1

198

927

JN4CD

NOMESCO Finland

Very extensive body CT

4.3

19.0

164

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

18.8

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

18.8

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

18.8

Z51.0

ICD-10 Finland

Radiotherapy session

70.3

18.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

18.6

256

1349

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.8

18.0

D33.0

ICD-10 Finland

Benign neoplasm: Brain, supratentorial

+∞

17.7

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

17.7

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

+∞

17.7

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

17.7

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

17.7

2151

FHL

Resection, big brain

+∞

17.7

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

+∞

17.7

1CD02

NOMESCO Finland

+∞

17.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

17.6

1288

10429

9537/0-C70.9

ICD-O-3

Transitional meningioma of meninges, NOS

95.6

17.6

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

17.6

217

1097

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

180.9

17.5

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

8.0

17.5

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.4

17.5

145

610

N03AX16

ATC

pregabalin; oral

1.5

17.2

677

4843

WX002

NOMESCO Finland

Sedation and analgesia

1.6

16.7

557

3833

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

+∞

16.7

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

16.7

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

2.5

16.6

129

522

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

90.5

16.6

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

90.5

16.6

L28

ICPC

Limited function/disability (L)

1.6

16.5

486

3244

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

16.4

385

2420

N06AX11

ATC

mirtazapine; oral

1.4

16.4

901

6897

H93.1

ICD-10 Finland

Tinnitus

2.1

16.3

197

986

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

16.3

205

1044

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

16.1

248

1362

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.1

16.1

282

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.7

16.1

192

J01DB01

ATC

cefalexin; oral

1.4

15.9

2268

20465

UJF32

NOMESCO Finland

Coloscopy

1.5

15.8

694

5072

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

15.6

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

15.6

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

+∞

15.6

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

15.6

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

15.6

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

15.6

R4120

NOMESCO Finland

Occupational therapy

2.1

15.6

185

918

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

160.7

15.5

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

160.7

15.5

R53

ICD-10 Finland

Malaise and fatigue

1.5

15.5

570

4006

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

10.8

15.4

G44.2

ICD-10 Finland

Tension-type headache

1.7

15.4

383

2440

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

9.5

15.4

AA1AA

NOMESCO Finland

Head X-ray examination

7.0

15.3

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

5.9

15.2

2250A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

45.2

15.1

N02AA05

ATC

oxycodone; systemic

1.7

15.0

314

1907

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

14.9

1048

8353

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.2

14.9

135

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.7

14.9

101

380

S06.0

ICD-10 Finland

Concussion

1.8

14.8

273

1592

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

31.8

14.8

ZX112

NOMESCO Finland

Subcutaneous

5.8

14.8

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.5

14.8

196

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

14.7

593

4247

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

14.6

L01AX03

ATC

temozolomide; systemic

+∞

14.6

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

14.6

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

8.9

14.4

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

14.3

371

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

4.1

14.3

136

H02AB06

ATC

prednisolone; systemic

1.4

14.2

1286

10664

G91.1

ICD-10 Finland

Obstructive hydrocephalus

9.1

14.2

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.5

14.0

194

ZX120

NOMESCO Finland

Intravenous

1.9

14.0

196

1039

A28

ICPC

Limited function/disability NOS

1.6

14.0

428

2873

R50.9

ICD-10 Finland

Fever, unspecified

1.7

13.9

302

1851

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

15.8

13.9

AAK10

NOMESCO Finland

Repair of dura

23.9

13.8

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

2.9

13.7

287

R13

ICD-10 Finland

Dysphagia

2.0

13.6

187

984

ZXC86

NOMESCO Finland

Use of endoscopic device

7.6

13.6

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

13.5

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

+∞

13.5

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

13.5

HAC25

NOMESCO Finland

Radical mastectomy

+∞

13.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

13.5

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

13.5

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

13.5

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

13.5

192

1025

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

140.6

13.5

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

140.6

13.5

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.0

13.4

268

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

6.5

13.4

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

21.2

13.3

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

11.5

13.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

13.1

210

1173

WX892

NOMESCO Finland

Monitored bed care

1.9

13.0

190

1023

R4150

NOMESCO Finland

Neuropsychological rehabilitation

5.6

13.0

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

8.1

12.8

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.6

12.7

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.7

12.6

308

N01

ICPC

Headache

1.7

12.6

243

1438

2396A

ICD-9 Finland

Neoplasm of unspecified nature, Brain

70.1

12.6

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

12.5

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

+∞

12.5

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

12.5

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

12.5

2040A

ICD-9 Finland

Lymphoid leukaemia, Acute

+∞

12.5

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

12.5

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

12.5

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

12.5

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

12.5

JN6AD

NOMESCO Finland

CT of torso and neck

11.0

12.5

R11

ICD-10 Finland

Nausea and vomiting

1.8

12.5

210

1188

D33.37

ICD-10 Finland

Another benign tumor of the cranial nerves

130.5

12.4

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

130.5

12.4

XW000

NOMESCO Finland

Bone marrow biopsy

2.6

12.4

345

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

4.3

12.4

106

DFF00

NOMESCO Finland

Pure tone audiometry

1.7

12.3

261

1591

G51.0

ICD-10 Finland

Bell palsy

2.8

12.2

279

22500

ICD-8 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

37.7

12.2

Q85.01

ICD-10 Finland

Neurofibromatosis, type 2

37.7

12.2

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

3.8

12.1

133

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

26.8

12.0

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.9

12.0

241

D31.6

ICD-10 Finland

Benign neoplasm: Orbit, unspecified

21.3

12.0

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

11.9

118

543

C90.0

ICD-10 Finland

Multiple myeloma

46.8

11.9

D33.39

ICD-10 Finland

Benign tumor of the cranial nerves UNS

46.8

11.9

R51

ICD-10 Finland

Headache

2.0

11.8

143

719

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

11.7

470

3351

ZXA10

NOMESCO Finland

Bilateral

1.4

11.7

541

3969

R4130

NOMESCO Finland

Speech therapy

3.0

11.7

218

G40.89

ICD-10 Finland

Other epilepsy

7.7

11.6

2159

FHL

Other measure in this category

65.2

11.6

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

65.2

11.6

Z31.5

ICD-10 Finland

Genetic counselling

2.5

11.6

381

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

19.0

11.6

N29

ICPC

Neurological sympt/complt other

3.0

11.6

214

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

11.5

207

1201

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

11.5

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

11.5

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

+∞

11.5

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

11.5

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

11.5

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

11.5

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

11.5

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

11.5

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

11.5

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

11.5

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

11.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

11.5

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

11.5

9532/0-C70.9

ICD-O-3

Fibrous meningioma of meninges, NOS

+∞

11.5

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

120.4

11.4

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

120.4

11.4

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

11.1

248

1534

N03AX12

ATC

gabapentin; oral

1.5

11.1

436

3092

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.9

11.0

227

G40

ICD-10 Finland

Epilepsy

4.8

11.0

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

6.9

10.8

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

15.5

10.8

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

15.5

10.8

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

10.8

178

1004

N02AX02

ATC

tramadol; systemic, rectal

1.3

10.8

1104

9210

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

10.8

120

583

H05.2

ICD-10 Finland

Exophthalmic conditions

8.9

10.7

TQW99

NOMESCO Finland

Other minor procedure on skin

2.2

10.7

103

469

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

7.2

10.7

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

28.1

10.7

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

28.1

10.7

A02BC05

ATC

esomeprazole; systemic

1.3

10.7

1139

9553

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

10.7

253

1590

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

10.7

284

1842

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

10.5

761

6021

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

8.5

10.5

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

10.5

1683

14902

D33.45

ICD-10 Finland

Benign Schwannom in the nerve root of the spinal cord

14.2

10.5

102

Kela drug reimbursment

Diabetes insipidus

14.2

10.5

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

110.4

10.4

PJW99

NOMESCO Finland

Other operation on lymphatic system

110.4

10.4

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

10.4

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

10.4

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

10.4

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

+∞

10.4

9533/0-C70.0

ICD-O-3

Psammomatous meningioma of cerebral meninges

+∞

10.4

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

10.4

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

+∞

10.4

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

10.4

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

10.4

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

10.4

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

10.3

413

2940

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

8.2

10.3

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.0

10.3

128

653

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

8.8

10.3

KAC10

NOMESCO Finland

Total nephrectomy with capsule

23.4

10.2

H46

ICD-10 Finland

Optic neuritis

4.6

10.2

D33.43

ICD-10 Finland

Spinal cord

40.2

10.0

N05BA01

ATC

diazepam; systemic, rectal

1.5

9.9

366

2559

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.3

9.9

152

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

9.8

160

898

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

12.2

9.8

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

9.8

257

N06AX16

ATC

venlafaxine; oral

1.5

9.8

323

2204

9560/0-C72.4

ICD-O-3

Schwannoma, NOS, of acoustic nerve

10.6

9.8

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.6

9.7

269

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

9.7

166

948

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.8

9.7

206

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

9.6

135

721

N03AX09

ATC

lamotrigine; oral

2.1

9.6

109

535

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

10.0

9.5

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

9.5

530

4014

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

9.5

1255

10781

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

9.5

106

517

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.5

9.4

294

D33.40

ICD-10 Finland

Benign glioma of the spinal cord (grade I)

100.3

9.4

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

100.3

9.4

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

100.3

9.4

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

100.3

9.4

N03AX11

ATC

topiramate; oral

2.5

9.4

306

N80

ICPC

Head injury other

3.0

9.4

170

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

9.4

20400

ICD-8 Finland

Lymphatic leukaemia, Acute

+∞

9.4

WW300

NOMESCO Finland

Transfer of autologic stem cells

+∞

9.4

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

+∞

9.4

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

9.4

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

9.4

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

9.4

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

9.4

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

9.4

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

+∞

9.4

L04AX04

ATC

lenalidomide; oral

+∞

9.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

9.4

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

9.4

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

9.4

S82

ICPC

Naevus/mole

1.5

9.4

295

1991

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.4

9.3

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

9.5

9.3

P20

ICPC

Memory disturbance

1.5

9.2

358

2530

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.3

9.2

375

A02BC03

ATC

lansoprazole; oral

1.3

9.1

820

6681

A02BC01

ATC

omeprazole; systemic

1.3

9.1

755

6080

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

4.5

9.1

J01MA02

ATC

ciprofloxacin; systemic

1.3

9.1

968

8072

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

9.1

182

1094

G91.0

ICD-10 Finland

Communicating hydrocephalus

5.1

9.1

TQW20

NOMESCO Finland

Tatoe

36.8

9.0

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

9.0

279

1879

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

9.0

192

1173

D70.82

ICD-10 Finland

Drug-induced neutropenia

6.5

8.9

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

8.9

885

7303

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.1

8.9

AAK40

NOMESCO Finland

Closure of cerebrospinal fluid fistula

24.1

8.9

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.9

8.9

119

623

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

3.4

8.9

122

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.9

8.8

176

CE2W4

NOMESCO Finland

Eye movement mapping

9.5

8.8

A06AD11

ATC

lactulose; oral

1.4

8.8

365

2617

N05BA09

ATC

clobazam; oral

5.9

8.7

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

8.7

427

3154

TQB05

NOMESCO Finland

Puncture of skin of trunk

7.2

8.7

G93.0

ICD-10 Finland

Cerebral cysts

7.2

8.7

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.6

8.7

103

N07CA01

ATC

betahistine; oral

1.6

8.7

209

1318

G04CA02

ATC

tamsulosin; oral

1.5

8.7

356

2543

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

8.7

810

6627

D33.3

ICD-10 Finland

Benign neoplasm: Cranial nerves

14.1

8.7

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.1

8.7

146

AAE99

NOMESCO Finland

Other operation by cranial base approach

50.1

8.7

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

50.1

8.7

K07.60

ICD-10 Finland

Snapping jaw

1.9

8.7

120

640

SPAT1216

SPAT

Assessment of functional ability

1.4

8.7

426

3150

H54.4

ICD-10 Finland

Blindness, monocular

6.6

8.6

C08CA01

ATC

amlodipine; oral

1.3

8.6

985

8275

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

8.6

545

4208

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

8.6

129

706

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

8.6

272

1838

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

8.6

292

2006

N88

ICPC

Epilepsy

4.6

8.6

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

16.3

8.5

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

16.3

8.5

UDC00

NOMESCO Finland

Ear microscopy

1.7

8.5

178

1080

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

8.5

185

1138

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

4.4

8.5

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.8

8.5

189

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

5.6

8.4

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

90.3

8.4

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

90.3

8.4

T32.0

ICD-10 Finland

Corrosions involving less than 10% of body surface

90.3

8.4

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

90.3

8.4

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

90.3

8.4

C43

ICD-10 Finland

Malignant melanoma of skin

90.3

8.4

153

Kela drug reimbursment

Lenalidomid

90.3

8.4

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.1

8.4

139

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

8.3

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

+∞

8.3

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

+∞

8.3

D43.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system

+∞

8.3

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

8.3

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

8.3

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

8.3

L02BA03

ATC

fulvestrant; parenteral

+∞

8.3

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

+∞

8.3

192

Kela drug reimbursment

Fulvestrant

+∞

8.3

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

8.3

251

1677

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

8.3

271

1845

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

10.8

8.3

A02BA02

ATC

ranitidine; systemic

1.3

8.3

548

4259

M03BX01

ATC

baclofen; systemic

2.8

8.3

174

SPAT1053

SPAT

Memory test

1.4

8.1

431

3233

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

33.4

8.1

D42.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Meninges, unspecified

33.4

8.1

ZZR10

NOMESCO Finland

Flap of skin and muscle

17.2

8.1

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

17.2

8.1

KCD02

NOMESCO Finland

Transurethral resection of bladder

6.8

8.1

N17

ICPC

Vertigo/dizziness

1.5

8.0

306

2152

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

8.0

402

Z71.8

ICD-10 Finland

Other specified counselling

1.3

8.0

552

4320

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.5

8.0

246

G47.3

ICD-10 Finland

Sleep apnoea

1.4

7.9

487

3737

H03AA01

ATC

levothyroxine sodium; systemic

1.3

7.9

697

5648

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.9

7.8

103

540

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

7.8

905

7600

S77

ICPC

Malignant neoplasm of skin

10.8

7.8

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

7.8

303

2139

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

7.7

188

1191

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

7.7

286

AA6AD

NOMESCO Finland

Cranial bones CT examination

45.1

7.7

XX1AD

NOMESCO Finland

Other CT-examination

45.1

7.7

23810

ICD-8 Finland

Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain

45.1

7.7

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

45.1

7.7

ABB10

NOMESCO Finland

Resection of lesion of spinal canal

45.1

7.7

AWW99

NOMESCO Finland

Other reoperation in surgery of the nervous system

15.0

7.7

HA1SA

NOMESCO Finland

Expansion mammography

15.0

7.7

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

7.7

896

7523

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

7.7

138

805

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.1

7.7

396

N06AB10

ATC

escitalopram; oral

1.4

7.6

456

3484

D33.7

ICD-10 Finland

Benign neoplasm: Other specified parts of central nervous system

18.4

7.6

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

7.6

156

947

S29

ICPC

Skin symptom/complaint other

1.4

7.6

407

3054

HAE99

NOMESCO Finland

Other reconstruction of breast

11.9

7.6

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

7.6

404

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.8

7.6

161

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

7.5

147

879

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

10.0

7.5

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

7.5

687

5590

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

80.3

7.4

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

80.3

7.4

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

80.3

7.4

XX1XN

NOMESCO Finland

Other isotope examination

80.3

7.4

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

13.4

7.4

ZXC96

NOMESCO Finland

Robot assisted procedure

4.1

7.4

N06AX26

ATC

vortioxetine; oral

1.8

7.3

122

693

H50.2

ICD-10 Finland

Vertical strabismus

3.9

7.3

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.9

7.3

E23.2

ICD-10 Finland

Diabetes insipidus

8.4

7.3

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

+∞

7.3

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

7.3

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

7.3

C71.09

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology

+∞

7.3

C71.12

ICD-10 Finland

Malignant tumor of frontal lobe grade III glioma

+∞

7.3

394

Kela drug reimbursment

Palbociclib

+∞

7.3

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

7.3

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

7.3

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

+∞

7.3

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

7.3

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

7.3

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

7.3

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

7.3

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

7.3

D33.01

ICD-10 Finland

Medial ganglion glioma of the cerebrum

+∞

7.3

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

7.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

7.3

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

7.3

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

L01XE33

ATC

[U] palbociclib; oral

+∞

7.3

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

7.3

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

7.3

1501

Kela drug reimbursment

Palbociclib

+∞

7.3

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

7.3

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

7.3

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

+∞

7.3

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.3

7.3

275

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

7.3

104

562

R55

ICD-10 Finland

Syncope and collapse

1.5

7.2

274

1928

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

15.8

7.2

N18

ICPC

Paralysis/weakness

2.4

7.2

239

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.6

7.2

185

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

7.2

1184

10338

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

7.2

184

1185

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.9

7.2

107

586

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

30.1

7.1

H01CB02

ATC

octreotide; parenteral

30.1

7.1

Q85.1

ICD-10 Finland

Tuberous sclerosis

30.1

7.1

K91

ICPC

Cerebrovascular disease

2.7

7.1

162

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

20.0

7.1

J02AC01

ATC

fluconazole; systemic

1.2

7.1

1097

9501

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

7.1

902

7642

BAA60

NOMESCO Finland

Total thyroidectomy

2.5

7.1

205

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

7.1

273

N03AX15

ATC

zonisamide; oral

12.0

7.1

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

7.0

372

2783

SPAT1043

SPAT

Audiometry

1.4

7.0

278

1973

WW500

NOMESCO Finland

Blood transfusion

2.4

7.0

238

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

7.0

2465

23365

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

7.0

1590

14356

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

6.9

216

1455

N99

ICPC

Neurological disease other

2.8

6.9

148

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

2.2

6.9

293

G04BD12

ATC

mirabegron; oral

1.5

6.8

266

1879

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

6.8

301

2182

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.3

6.8

246

S09.9

ICD-10 Finland

Unspecified injury of head

3.0

6.8

121

KMAK

NOMESCO Finland

1.2

6.8

1269

11210

G50.1

ICD-10 Finland

Atypical facial pain

2.4

6.8

217

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

16.7

6.7

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.3

6.7

237

N06AB04

ATC

citalopram; systemic

1.3

6.7

561

4503

N28

ICPC

Limited function/disability (N)

2.6

6.7

184

AAF00

NOMESCO Finland

Ventriculostomy

3.6

6.7

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.8

6.6

139

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

6.6

389

2960

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

6.6

170

1094

U04

ICPC

Incontinence urine

1.7

6.6

121

713

NA2DG

NOMESCO Finland

Thoracal spine very extensive MRI examination with high intensity magnet

8.7

6.5

N63

ICD-10 Finland

Unspecified lump in breast

1.7

6.5

120

705

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

6.5

361

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

6.5

412

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.1

6.5

326

KED22

NOMESCO Finland

Transurethral resection of prostate

1.9

6.4

428

R51.81

ICD-10 Finland

Facial pain NOS

2.2

6.4

269

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

6.4

307

2256

N05BA04

ATC

oxazepam; oral

1.3

6.4

630

5160

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

70.0

6.4

ZZR50

NOMESCO Finland

Mucoperiosteal flap

70.0

6.4

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

70.0

6.4

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

70.0

6.4

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

70.0

6.4

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

70.0

6.4

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

70.0

6.4

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

7.4

6.4

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

6.4

491

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

14.3

6.4

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

0.4

6.4

732

I25.2

ICD-10 Finland

Old myocardial infarction

0.5

6.4

1039

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

6.3

153

970

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

6.3

1178

10375

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

6.3

137

847

Z00.0

ICD-10 Finland

General medical examination

1.3

6.3

439

3432

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

11.0

6.3

ZZC00

NOMESCO Finland

Graft of fascia

11.0

6.3

G41.0

ICD-10 Finland

Grand mal status epilepticus

11.0

6.3

9101

FHL

Bone biopsy

9.3

6.3

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

6.3

533

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.8

6.3

133

AAK99

NOMESCO Finland

Other operation on skull or dura

18.0

6.3

D33.06

ICD-10 Finland

Plexus papilloma of the ventricle of the brain

+∞

6.2

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

6.2

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

+∞

6.2

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

+∞

6.2

D33.15

ICD-10 Finland

Another benign tumor of the cerebellum

+∞

6.2

D77

ICPC

Malignant digestive neopl other/NOS

+∞

6.2

1XC03

NOMESCO Finland

+∞

6.2

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

+∞

6.2

D33

ICD-10 Finland

Benign neoplasm of brain and other parts of central nervous system

+∞

6.2

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

6.2

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

6.2

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

6.2

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

6.2

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

6.2

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

6.2

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

+∞

6.2

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

6.2

197

Kela drug reimbursment

Sunitinib

+∞

6.2

C71.19

ICD-10 Finland

Malignant tumor of frontal lobe other or unspecified histology

+∞

6.2

C71.89

ICD-10 Finland

Overall malignant tumor of the brain other or unspecified histology

+∞

6.2

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

6.2

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

+∞

6.2

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

6.2

L01XE04

ATC

[U] sunitinib; oral

+∞

6.2

L01CA04

ATC

vinorelbine; systemic

+∞

6.2

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

+∞

6.2

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

6.2

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

6.2

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

6.2

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

6.2

C71.9

ICD-10 Finland

Malignant neoplasm: Brain, unspecified

+∞

6.2

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

6.2

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

+∞

6.2

Z85.6

ICD-10 Finland

Personal history of leukaemia

+∞

6.2

K90

ICPC

Stroke/cerebrovascular accident

2.0

6.2

404

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.8

6.2

107

618

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

6.2

177

1172

D35.30

ICD-10 Finland

Craniopharyngoma

26.7

6.2

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

26.7

6.2

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

26.7

6.2

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

6.2

795

6722

C09CA01

ATC

losartan; oral

1.3

6.2

642

5295

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

6.2

286

2090

R4190

NOMESCO Finland

Nutritional therapy

2.3

6.2

232

R33

ICD-10 Finland

Retention of urine

1.6

6.2

137

853

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

6.2

238

1682

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

6.1

304

2249

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.8

6.1

100

569

N03AX23

ATC

brivaracetam; systemic

12.5

6.1

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.4

6.1

197

H90.5

ICD-10 Finland

Sensorineural hearing loss, unspecified

3.0

6.1

108

N30.0

ICD-10 Finland

Acute cystitis

1.3

6.0

372

2852

SPAT1240

SPAT

Therapeutic discussion

1.5

6.0

211

1460

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726)

583

829

8.26

307.65

1.4

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

383

126

34.06

307.65

1.6

1.9

—

(3003396) Base excess in Arterial blood by calculation

891

2804

3.93

243.89

5.6

6.9

1.0

1.5

mmol/l

3.07

646

2172

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

890

2828

3.89

239.88

5.6

6.9

4.9

5.1

kpa

6.93

859

2685

(3027801) Oxygen [Partial pressure] in Arterial blood

889

2826

3.89

239.42

5.6

6.9

16.4

11.6

kpa

67.37

858

2674

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

542

1198

5.18

234.14

4.9

8.8

24.0

24.6

mmol/l

3.95

528

1093

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2259

14291

2.68

161.43

7.6

5.4

1.2

mmol/l

9.16

1966

11941

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2088

12838

2.58

156.28

6.5

5.0

1.2

mmol/l

10.98

1921

11281

(40768804) Tissue Pathology biopsy report

1722

9733

2.53

153.42

2.4

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

1431

7699

2.47

138.10

2.4

2.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2410

16396

2.55

137.00

5.6

4.1

6.6

6.7

mmol/l

1.61

2322

15197

(3033658) Prothrombin time (PT) actual/Normal

1222

6413

2.40

121.27

3.8

3.3

94.0

90.5

5.29

1184

6224

(3018677) aPTT in Platelet poor plasma by Coagulation assay

880

3986

2.62

119.80

2.1

1.9

28.9

29.6

2.85

850

3846

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1846

11780

2.22

112.15

3.9

3.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1116

5893

2.32

106.61

2.3

2.0

—

(3032080) INR in Blood by Coagulation assay

1741

11022

2.17

105.81

8.0

9.5

1.2

1.3

inr

2.43

448

3136

(3044290) Cell count panel - Cerebral spinal fluid

244

529

4.89

105.56

1.6

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

162

247

6.83

101.80

1.8

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

566

2308

2.74

92.95

7.2

7.7

121.3

g/l

0.01

550

2206

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

101

10.59

91.55

2.3

52.2

55.2

umol/l

0.33

(3016502) Oxygen saturation in Arterial blood

593

2523

2.63

89.24

7.0

7.3

97.1

95.2

15.12

580

2410

(3016018) Differential panel - Cerebral spinal fluid

158

269

6.11

89.06

1.7

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

237

590

4.24

85.91

1.6

1.3

72.5

26.6

e6/l

0.92

182

457

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

237

592

4.22

85.52

1.7

1.4

1576.9

1419.8

e6/l

0.09

186

486

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

409

1476

3.01

83.86

7.0

8.4

0.7

1.28

409

1467

(3014007) Fractional oxyhemoglobin in Arterial blood

408

1482

2.99

82.65

7.1

8.5

95.5

93.3

15.41

408

1476

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

408

1491

2.97

81.72

7.1

8.4

1.2

1.4

4.22

408

1483

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1456

9344

1.97

77.64

2.3

2.1

149.1

209.2

u/l

2.12

1383

8696

(3036481) Cortisol [Moles/volume] in Serum or Plasma

562

2482

2.51

77.47

2.8

1.7

372.6

369.7

nmol/l

0.11

522

2227

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

104

131

8.15

77.27

1.9

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1903

13390

1.94

76.82

5.9

3.7

10.5

11.1

umol/l

1.37

1792

12430

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

236

673

3.69

70.55

1.3

1.2

705.6

516.1

mg/l

2.62

223

635

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

217

589

3.86

69.67

1.3

1.2

3.6

3.8

mmol/l

1.42

194

550

(3002256) Pathology report gross observation

507

2270

2.45

67.22

1.3

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

378

1530

2.65

61.69

3.6

1.4

15.1

12.0

ug/l

0.10

303

1140

(3023410) Appearance of Cerebral spinal fluid

127

251

5.21

60.92

1.9

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1995

14984

1.78

58.20

9.2

6.4

4.1

4.2

e9/l

0.46

1757

12836

(3014576) Chloride [Moles/volume] in Serum or Plasma

603

3079

2.16

57.97

6.3

6.0

104.7

104.0

mmol/l

2.87

593

3004

(3012095) Magnesium [Moles/volume] in Serum or Plasma

706

3919

2.01

53.85

2.7

2.4

0.8

mmol/l

0.93

654

3571

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2615

21537

1.88

53.68

8.1

5.4

78.1

76.2

u/l

1.41

2460

19824

(3024561) Albumin [Mass/volume] in Serum or Plasma

1621

11682

1.73

52.66

4.8

3.6

35.1

35.8

g/l

4.80

1499

10637

(3023368) Bacteria identified in Blood by Culture

1044

6641

1.82

52.26

4.6

3.8

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

189

576

3.41

50.88

2.6

1.7

423.0

303.4

mu/l

2.85

181

516

(3019060) Gas panel - Arterial blood

375

1700

2.35

47.53

5.8

5.1

—

(3018418) pH of Serum or Plasma

1228

8457

1.70

45.11

4.6

3.2

7.4

0.33

208

1442

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

14.30

45.07

7.1

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

423

2067

2.19

44.69

5.7

6.6

8.1

10.2

mmol/l

7.35

397

1950

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

190

5.06

43.95

1.3

1.2

2.5

2.1

mmol/l

1.29

179

(3031040) Bacteria [#/volume] in Urine by Automated count

2337

19087

1.69

43.77

5.6

4.7

763.0

3220.8

e6/l

2.70

245

(40768793) Breast Pathology biopsy report

105

240

4.48

42.35

1.4

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

356

1656

2.28

42.31

9.0

7.0

25.0

24.8

mmol/l

0.42

342

1516

(3002582) Erythrocytes [#/volume] in Urine

1149

8017

1.65

38.76

3.5

3.0

51.5

74.3

e6/l

0.81

907

6007

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

7.24

37.29

2.6

1.9

0.7

1.2

ug/l

1.04

(42870588) Differential panel, method unspecified - Blood

1253

9006

1.61

37.11

5.9

5.5

—

(3001604) Monocytes [#/volume] in Blood

1747

13584

1.58

36.97

5.8

5.4

0.6

e9/l

0.15

1502

11622

(3026782) Osmolality of Urine

804

5162

1.73

36.83

3.1

2.6

525.6

527.3

mosm/kgh2o

0.07

706

4277

(3019069) Monocytes/100 leukocytes in Blood

1647

12644

1.58

36.76

6.3

5.9

8.6

0.00

1538

11637

(3022096) Basophils/100 leukocytes in Blood

1600

12210

1.58

36.59

6.1

5.7

0.7

1.56

1487

11187

(3006315) Basophils [#/volume] in Blood

1753

13662

1.57

36.57

5.9

5.4

0.0

e9/l

0.76

1513

11692

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

693

4280

1.77

36.34

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1283

9323

1.60

36.03

3.6

2.1

2.4

mmol/l

0.19

1087

7750

(3030467) Casts [#/volume] in Urine by Automated count

1071

7451

1.63

35.97

3.4

2.9

0.4

e6/l

0.03

839

5514

(3006504) Eosinophils/100 leukocytes in Blood

1636

12582

1.57

35.94

6.1

5.6

2.7

3.0

5.20

1521

11518

(3002030) Lymphocytes/100 leukocytes in Blood

1670

12933

1.56

35.37

6.2

5.7

27.7

28.2

1.10

1550

11834

(3043409) Potassium [Moles/volume] in Arterial blood

203

795

2.65

34.98

5.4

4.1

3.8

mmol/l

2.44

198

752

(3019198) Lymphocytes [#/volume] in Blood

1774

13956

1.56

34.83

5.9

5.5

1.9

e9/l

0.59

1552

12165

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3131

28436

2.08

34.66

18.9

12.6

21.3

21.8

mg/l

0.43

2732

21923

(3013115) Eosinophils [#/volume] in Blood

1791

14154

1.55

34.20

6.1

5.6

0.2

e9/l

5.07

1563

12321

(3018095) Leukocytes [#/volume] in Urine

1308

9645

1.57

33.95

4.1

3.5

73.3

117.9

e6/l

2.26

967

6574

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

273

1249

2.29

33.54

8.4

9.8

—

(3018010) Neutrophils/100 leukocytes in Blood

1643

12825

1.54

32.59

6.0

5.6

57.6

57.2

0.77

1532

11791

(3003458) Phosphate [Moles/volume] in Serum or Plasma

558

3337

1.80

32.28

5.3

4.7

1.0

mmol/l

0.76

503

3045

(36304419) Bacteria [Presence] in Urine

1027

7239

1.60

31.91

3.3

2.9

—

(3000991) Gas panel - Venous blood

377

1999

1.99

31.56

7.2

7.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

217

923

2.44

31.44

5.1

3.8

1.2

1.4

mmol/l

2.22

217

899

(3026008) Bacteria identified in Urine by Culture

1294

9645

1.55

31.34

3.6

3.3

—

(40758558) Short blood count panel - Blood

918

6330

1.61

31.13

6.7

4.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2348

19935

1.56

30.69

5.4

4.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

21.04

30.30

1.3

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

388

2140

1.92

28.84

6.3

6.2

1.5

1.4

mmol/l

0.56

378

2069

(3013707) Erythrocyte sedimentation rate by Westergren method

2529

21969

1.56

28.58

4.6

4.2

12.8

12.5

mm/h

0.53

2351

20218

(3019550) Sodium [Moles/volume] in Serum or Plasma

3226

29954

2.17

28.49

22.6

15.0

139.6

139.8

mmol/l

2.42

3181

29120

(3020891) Body temperature

235

1081

2.26

28.44

5.3

4.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3230

30033

2.16

27.96

22.6

15.1

3.9

4.0

mmol/l

3.13

3181

29146

(1617658) Protocol used for examination of sentinel lymph nodes

64.54

27.94

1.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

823

5657

1.60

27.78

4.0

3.8

152.8

359.8

ng/l

2.81

627

4454

(40768795) Lymph node Pathology biopsy report

7.02

27.13

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

111

5.02

25.82

3.2

2.7

29.2

28.5

umol/l

0.15

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

626

4111

1.64

25.19

3.0

2.7

4.1

3.6

e6/l

0.47

354

2143

(3009214) Lutropin [Units/volume] in Serum or Plasma

112

383

2.99

24.91

1.6

1.3

12.3

12.4

u/l

0.03

304

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1441

11361

1.46

24.82

4.1

3.7

38.3

77.4

ng/l

0.85

1039

7782

(3007853) Bacteria identified in Skin by Aerobe culture

496

3079

1.71

24.70

1.7

1.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2629

23349

1.53

23.89

4.9

4.3

14.9

pmol/l

0.09

2401

21138

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

198

912

2.24

23.86

2.1

2.3

501.5

764.6

ug/l

0.40

182

847

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

413

2461

1.77

23.73

4.2

3.0

242.1

238.4

u/l

0.12

385

2281

(3042936) Bacteria identified in Isolate by Culture

540

3471

1.66

23.50

2.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

185

841

2.27

23.01

2.6

2.2

11.0

13.7

nmol/l

4.01

153

735

(3000850) Epithelial cells [#/volume] in Urine

798

5672

1.53

22.54

2.8

2.5

6.4

6.2

e6/l

0.16

720

4886

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2978

27336

1.65

22.17

5.9

5.1

3.2

2.0

mu/l

0.66

2736

24921

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

223

1112

2.07

21.96

6.0

5.3

1.5

1.6

1.73

207

1041

(3009466) Valproate [Moles/volume] in Serum or Plasma

107

385

2.84

21.74

3.6

5.1

348.4

368.1

umol/l

0.91

102

330

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

112

4.61

21.70

6.0

1.1

10.0

101.1

u/ml

1.31

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1106

8469

1.45

21.36

3.1

2.6

31.2

32.3

u/l

0.25

1035

7978

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

663

4588

1.55

20.98

2.8

2.6

1.0

1.4

e6/l

1.64

391

2604

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

113

431

2.68

20.56

1.2

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

470

3015

1.65

20.43

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2058

17685

1.41

20.19

3.5

2.9

47.6

43.7

u/l

1.30

1898

16138

(3044889) 12 lead EKG panel

2331

20477

1.43

20.12

4.3

3.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

447

2847

1.65

19.96

2.3

2.2

7.8

7.1

umol/l

0.22

372

2408

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

386

2367

1.71

19.89

2.5

2.2

30.3

37.9

u/l

2.03

335

1995

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

465

3002

1.63

19.66

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

309

1786

1.80

19.56

3.1

2.9

4.3

4.4

pmol/l

2.51

277

1551

(3019309) Folate [Moles/volume] in Red Blood Cells

818

6009

1.47

19.25

1.8

1108.1

1184.2

nmol/l

1.54

601

4486

(3007930) Methemoglobin/Hemoglobin.total in Blood

213

1107

1.98

18.70

6.1

5.3

0.9

1.40

198

1039

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

280

1594

1.82

18.62

1.7

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

266

1493

1.85

18.52

1.4

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1564

12958

1.38

18.39

2.1

2.0

97.9

97.3

pmol/l

0.17

765

6194

(3023323) Follitropin [Units/volume] in Serum or Plasma

191

961

2.05

18.36

1.5

1.3

31.7

33.6

iu/l

0.33

169

839

(3008295) Osmolality of Serum or Plasma

275

2.99

18.32

1.8

1.4

284.0

274.2

mosm/kgh2o

2.97

208

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3220

30455

1.85

18.22

21.8

14.5

74.3

74.6

umol/l

0.20

3220

30446

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

128

552

2.37

18.02

3.1

1.9

3122.0

80.5

u/ml

0.84

104

432

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

7.27

17.80

1.3

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1547

12844

1.37

17.73

2.5

2.3

77.9

79.8

nmol/l

1.73

1361

11300

(3035637) Corticotropin [Mass/volume] in Plasma

249

3.02

17.02

1.8

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

139

637

2.23

17.00

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2912

26950

1.51

16.95

17.0

11.5

78.7

77.2

ml/min/173m2

3.67

2578

21620

(40761511) CBC panel - Blood by Automated count

3139

29570

1.67

16.75

18.4

12.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

726

5347

1.45

16.52

3.2

2.2

2.5

mmol/l

0.55

617

4596

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

329

2030

1.69

16.48

2.1

2.0

0.2

g/l

1.69

299

1837

(3003694) ABO and Rh group [Type] in Blood

843

6387

1.42

16.43

1.3

—

(3021589) Normoblasts [#/volume] in Blood

1456

12076

1.36

16.34

10.4

8.3

0.0

e9/l

0.12

1182

9846

(43055514) Macroprolactin [Presence] in Serum or Plasma

6.80

16.13

1.6

—

(3039000) Anion gap in Blood

126

568

2.26

16.04

8.0

7.9

10.5

11.2

mmol/l

1.57

111

506

(3018572) Chloride [Moles/volume] in Blood

126

568

2.26

16.04

8.0

7.9

107.4

104.7

mmol/l

7.92

111

506

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

307

1874

1.70

15.99

1.7

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1119

8931

1.37

15.94

2.5

2.3

62.0

57.5

u/l

0.46

1011

8099

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

226

3.00

15.38

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

139

3.56

14.86

1.0

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

294

1813

1.68

14.73

3.1

2.3

9.8

10.7

g/l

3.46

267

1654

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

140

3.54

14.71

1.1

1.0

1.1

u/l

0.35

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

146

723

2.06

14.69

3.3

0.3

0.4

u/ml

0.12

422

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

183

989

1.90

14.34

1.8

1.7

—

(3047181) Lactate [Moles/volume] in Blood

159

821

1.98

14.26

7.3

6.7

1.3

mmol/l

0.54

145

716

(40768800) Prostate Pathology biopsy report

4.19

14.12

1.1

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

266

2.74

14.03

1.1

—

2.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

175

3.18

13.96

1.2

1.0

10.2

10.1

nmol/l

0.01

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

175

3.18

13.96

1.2

1.1

53.1

34.9

mg/l

1.03

148

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

6.51

13.64

2.0

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

215

1243

1.78

13.57

3.0

1.5

32.4

29.0

u/ml

0.13

206

1177

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

190

1061

1.84

13.45

2.1

1.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1418

11953

1.32

13.35

3.0

2.8

125.0

110.4

ug/l

1.38

1285

10937

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

906

7161

1.36

13.23

2.3

2.9

3.0

mg/l

0.19

760

6082

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

167

3.15

13.02

1.1

313.5

242.4

mg/l

0.95

149

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

254

2.71

13.00

1.1

—

47.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

122

592

2.10

12.99

2.9

2.5

3.4

3.5

g/l

0.14

116

552

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

359

2397

1.56

12.96

3.9

3.3

89.7

86.5

ng/l

0.30

305

2005

(3036489) Thrombin time

165

898

1.88

12.68

2.2

1.8

21.0

21.2

0.14

146

775

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

310

2011

1.59

12.67

2.2

2.4

17.5

25.8

au/ml

0.69

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

165

3.12

12.62

1.1

—

(3013512) EKG study

1074

8777

1.32

12.37

4.4

4.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

790

6178

1.36

12.21

1.9

1.7

1.5

1.1

mg/l

0.84

608

4712

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

3.29

12.16

1.0

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

282

1823

1.60

11.69

1.2

1.3

40.9

47.4

au/ml

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

396

2759

1.49

11.68

3.7

3.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

132

3.29

11.62

1.3

1.2

36.5

56.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

330

2218

1.54

11.54

2.4

1.5

65.2

66.8

g/l

4.19

296

1964

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

6.16

11.19

1.3

1.1

47.3

44.0

0.09

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3184

30509

1.56

10.94

12.4

9.2

25.0

24.3

u/l

1.13

3085

29144

(3021601) Nitrite [Presence] in Urine by Test strip

1635

14283

1.27

10.92

6.0

5.3

0.0

estimate

0.80

326

2422

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

208

2.72

10.88

2.8

2.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

119

612

1.98

10.86

2.7

2.3

181.8

185.3

0.17

114

576

(3035350) Ketones [Presence] in Urine by Test strip

1628

14229

1.27

10.77

4.3

3.9

0.0

estimate

0.00

318

2408

(3009261) Glucose [Presence] in Urine by Test strip

1649

14439

1.27

10.73

4.4

4.0

0.0

estimate

1.32

316

2404

(3019225) pH of Specimen

412

2947

1.45

10.60

5.0

3.6

—

(3003181) Sodium [Moles/volume] in Urine

108

543

2.02

10.52

1.3

72.5

61.6

mmol/l

1.64

434

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

349

2.26

10.24

2.0

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1065

8883

1.29

10.10

2.9

3.0

1470.2

1314.8

ng/l

0.54

913

7570

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

224

2.57

9.94

1.4

1.3

0.3

nmol/l

0.10

176

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

474

3518

1.40

9.91

2.9

2.5

21.2

22.4

0.94

418

2923

(3028026) IgM [Mass/volume] in Serum or Plasma

225

1439

1.60

9.77

1.9

1.4

1.3

1.2

g/l

0.19

201

1308

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

5.02

9.56

2.6

2.2

44.0

44.6

umol/l

0.03

(3008757) Leukocyte morphology finding [Identifier] in Blood

205

2.61

9.56

4.1

3.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

448

2.06

9.42

2.0

2.9

28.1

33.6

umol/l

2.44

389

(4027681)

134

3.01

9.41

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

292

2.32

9.38

3.9

3.0

2.0

1.2

0.55

212

(3004789) Transferrin [Mass/volume] in Serum or Plasma

504

3817

1.38

9.31

2.7

2.4

2.3

2.4

g/l

1.29

462

3494

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

220

2.52

9.28

1.8

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

308

2141

1.48

9.16

4.4

3.7

1.1

0.7

1.22

103

421

(3021440) Promyelocytes/100 leukocytes in Blood

298

2063

1.49

9.04

4.4

3.8

0.2

0.1

0.93

388

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

130

733

1.80

9.01

1.5

1.4

17.3

23.2

iu/ml

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

499

1.97

8.91

1.8

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

514

3931

1.36

8.91

8.0

6.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

202

2.55

8.80

2.0

1.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

184

1156

1.62

8.62

1.8

2.0

36.7

39.4

u/l

1.19

157

1008

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

324

2303

1.45

8.59

4.4

2.8

1.2

mmol/l

0.37

285

1912

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.68

8.44

1.0

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

481

1.96

8.44

1.9

1.4

—

(3007461) Platelets [#/volume] in Blood

3260

31601

1.56

8.33

28.5

18.7

254.5

254.4

e9/l

0.03

3205

30633

(3002385) Erythrocyte distribution width [Ratio]

2482

23128

1.26

8.28

23.2

15.1

13.8

13.7

4.50

2434

22551

(3009542) Hematocrit [Volume Fraction] of Blood

2688

25293

1.28

8.24

20.8

14.0

38.7

39.2

1.70

1816

17003

(3017143) Hepatitis C virus Ab [Presence] in Serum

314

2237

1.44

8.22

1.6

1.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

3261

31622

1.56

8.21

28.6

18.8

132.0

134.2

g/l

17.52

3230

31053

(3049717) Cytology report of Urine Cyto stain

131

762

1.75

8.20

2.3

1.8

—

(3024731) MCV [Entitic volume]

3260

31612

1.56

8.19

28.4

18.6

90.8

91.2

5.85

3227

31044

(3035941) MCH [Entitic mass]

3260

31615

1.55

8.15

28.4

18.6

30.1

30.3

6.09

3226

31047

(3021960) Folate [Moles/volume] in Serum or Plasma

871

7243

1.27

8.14

1.6

1.5

20.3

21.5

nmol/l

1.46

749

6042

(3026361) Erythrocytes [#/volume] in Blood

3260

31617

1.55

8.12

28.5

18.7

4.4

4.5

e12/l

4.83

3198

30520

(3010813) Leukocytes [#/volume] in Blood

3260

31619

1.55

8.10

28.5

18.7

6.9

6.6

e9/l

8.44

3199

30516

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

199

2.48

8.05

1.9

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

240

1628

1.51

8.05

3.7

3.4

5.2

kpa

0.17

212

1494

(3025159) Blasts/100 leukocytes in Blood

280

1970

1.46

7.84

4.4

3.8

0.0

0.3

0.51

339

(3009343) pH of Capillary blood

236

1608

1.50

7.76

3.7

3.4

7.4

1.75

198

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

151

928

1.66

7.75

2.2

1.8

2.6

1.6

ug/l

0.51

118

797

(3002032) Base excess in Venous blood by calculation

338

2473

1.41

7.64

3.9

3.3

1.6

2.1

mmol/l

1.62

282

2046

(40768797) Stomach Pathology biopsy report

524

4120

1.32

7.47

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

534

4212

1.32

7.44

2.8

2.4

12.5

13.0

umol/l

0.77

499

3837

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.61

7.40

1.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

258

2.23

7.38

2.2

2.6

256.0

604.7

u/ml

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1774

16049

1.22

7.37

2.8

2.7

—

(3052851) Hemolysis interference index of Serum or Plasma

132

794

1.69

7.36

3.2

3.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

226

1544

1.50

7.35

3.7

3.3

2.0

mmol/l

0.03

159

1149

(4281824)

184

2.46

7.32

1.2

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

274

1947

1.44

7.29

2.2

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

206

1383

1.52

7.28

1.4

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

423

1.94

7.20

1.6

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

198

2.39

7.18

3.6

2.8

64.1

58.6

0.96

127

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

538

1.83

7.17

1.5

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

538

1.83

7.17

1.5

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

7.71

7.12

1.3

—

(3012544) pH of Venous blood

346

2576

1.38

7.05

3.8

3.3

—

7.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

398

3030

1.35

7.05

1.7

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

868

7321

1.25

7.03

2.7

2.3

3288.5

6049.1

umol/l

1.49

732

6188

(3021447) Carbon dioxide [Partial pressure] in Venous blood

335

2484

1.39

7.00

3.9

3.3

5.7

5.9

kpa

1.55

329

2413

(3042111) Morphology [Interpretation] in Bone marrow Narrative

324

2.06

6.98

1.8

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2871

27388

1.29

6.95

6.3

6.1

39.6

40.0

mmol/mol

1.73

2644

25194

(3037522) Nuclear Ab [Titer] in Serum

507

4017

1.31

6.81

1.4

1.3

526.7

571.1

titre

0.19

107

911

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

223

2.26

6.74

1.7

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

346

1.98

6.55

4.6

5.2

161.1

382.8

iu/ml

—

(3011985) Renin [Units/volume] in Plasma

399

1.90

6.35

1.6

1.4

52.7

50.0

mu/l

0.04

357

(3012501) Base excess in Blood by calculation

560

1.75

6.32

3.1

3.5

2.4

2.5

mmol/l

0.21

378

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

290

2.05

6.26

1.7

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

137

870

1.60

6.23

3.7

1.5

30.6

41.9

mg/l

4.16

112

705

(3027945) Reticulocytes/100 erythrocytes in Blood

379

2919

1.34

6.21

2.5

2.2

1.8

0.14

341

2523

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

3.06

6.18

1.3

1.1

18.4

30.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2986

28721

1.29

6.13

5.2

4.9

5.9

mmol/l

2.32

2704

26013

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

343

2610

1.35

6.10

1.6

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

271

1988

1.39

6.05

4.4

3.6

1.1

0.5

0.56

316

(3010421) pH of Blood

110

666

1.67

6.05

3.0

3.3

7.4

0.02

548

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

132

837

1.60

6.05

3.8

1.5

1.1

2.1

ratio

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

136

869

1.59

6.04

3.8

1.5

28.8

37.9

mg/l

0.67

111

701

(3037756) Immunofixation for Serum or Plasma

502

1.77

5.99

1.5

1.2

—

(3051651) Icteric interference index of Serum or Plasma

124

2.60

5.87

3.2

4.1

—

(40765096) Chromosome analysis panel by Banding

4.18

5.82

1.1

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

2.80

5.72

3.2

2.3

837.6

742.9

e6/l

0.24

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

802

6839

1.22

5.71

1.7

11350129.0

31409552.7

pmol/l

0.88

652

5578

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

346

2663

1.33

5.70

2.4

3.0

163.9

191.4

ng/l

1.01

314

2428

(1616796) Gas panel - Central venous blood

534

1.72

5.64

2.8

3.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

124

789

1.59

5.63

1.4

1.2

—

(3022145) Colonoscopy Study observation

378

2958

1.31

5.54

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

278

2081

1.37

5.50

3.8

2.8

4.8

4.5

kpa

0.92

269

2014

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.15

5.46

1.0

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

16.04

5.41

2.5

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

141

933

1.53

5.41

2.0

1.7

275.0

399.2

titre

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

340

2631

1.32

5.40

2.4

2.5

6.7

7.0

ug/l

0.09

277

2247

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.10

5.33

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

155

2.34

5.33

1.3

1.2

—

(3011412) CD3 cells [#/volume] in Blood

144

2.37

5.22

2.8

2.2

1.0

1.1

e9/l

0.08

(3000494) Fungus identified in Specimen by Culture

408

3254

1.29

5.19

1.5

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.01

5.16

1.1

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

328

1.88

5.08

3.1

1.9

570.2

62.1

u/ml

0.45

291

(40760888) Immunoglobulin light chains.free panel - Serum

102

636

1.62

5.06

3.9

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

498

1.70

5.06

1.6

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

409

1.78

5.03

1.7

0.7

0.8

g/l

0.48

308

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

166

2.24

5.00

2.5

2.4

—

(3023520) Reticulocytes [#/volume] in Blood

285

2176

1.34

4.98

2.9

2.2

71.1

69.7

e9/l

0.29

228

1641

(3028433) Virus identified in Specimen by Culture

2.82

4.97

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

186

2.16

4.96

1.5

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

543

1.66

4.83

2.7

2.4

15.4

16.4

1.23

277

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

385

1.78

4.82

1.4

1.3

—

nmol/l

—

(3022313) Gas panel - Capillary blood

167

1175

1.44

4.77

3.9

3.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

144

2.30

4.77

1.2

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

372

1.79

4.75

1.5

1.3

261.8

282.7

pmol/l

0.23

278

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

109

703

1.57

4.73

1.9

2.1

12.3

11.4

mg/l

0.16

644

(3028626) Oxygen [Partial pressure] in Capillary blood

539

1.65

4.71

2.8

2.7

8.5

8.0

kpa

0.50

493

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

290

2242

1.32

4.66

3.1

2.3

62.5

64.7

ml/min/173m2

0.38

108

895

(3020876) Protein [Mass/time] in 24 hour Urine

198

2.08

4.65

2.4

1.5

—

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

805

6993

1.20

4.62

4.1

4.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

166

2.18

4.58

1.6

1.4

—

(3037121) Protein [Mass/volume] in Urine

128

862

1.50

4.58

2.7

2.5

0.3

g/l

0.11

249

(3022217) INR in Platelet poor plasma by Coagulation assay

471

3885

1.25

4.52

24.5

26.9

1.4

inr

0.03

550

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

228

1.99

4.49

2.1

1.8

4633.9

597.0

u/ml

0.43

222

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

142

2.27

4.47

2.3

2.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

843

7376

1.19

4.44

4.3

3.5

—

(3003338) MCHC [Mass/volume]

2495

23772

1.18

4.42

24.6

16.7

331.2

331.3

g/l

0.28

2473

23600

(3017732) Neutrophils [#/volume] in Blood

254

1944

1.33

4.39

2.6

2.8

4.1

4.0

e9/l

0.08

183

1438

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1209

10914

1.17

4.34

4.8

4.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.34

4.32

3.9

2.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

112

744

1.52

4.29

1.8

4.0

4.6

iu/l

0.23

267

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.88

4.25

1.0

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.15

4.20

1.3

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

410

1.70

4.18

1.4

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

116

782

1.50

4.16

2.9

3.1

—

(3029937) Albumin [Presence] in Urine by Test strip

868

7653

1.18

4.15

4.9

4.5

0.0

estimate

1.28

315

2415

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.80

4.11

1.2

189.5

316.6

pmol/l

1.14

(21494434) Karyotype in Bone marrow

195

2.01

4.07

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

145

1026

1.43

4.07

4.3

3.6

25.0

25.1

mmol/l

0.10

130

932

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

165

1195

1.40

4.06

3.8

3.6

24.0

24.4

mmol/l

0.87

156

1058

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

627

1.55

4.00

1.4

1.3

—

(40758292) HTLV I+II Ab panel - Serum

6.44

3.98

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

596

1.56

3.97

2.1

2.2

125.6

130.0

g/l

1.06

436

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.65

3.92

1.0

1.2

—

(3021901) Oxygen saturation in Capillary blood

449

1.64

3.91

2.5

2.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

631

1.54

3.89

2.7

3.0

24.9

25.1

mmol/l

0.13

551

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

185

2.01

3.88

2.2

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

185

2.01

3.88

2.2

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

185

2.01

3.88

2.2

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

614

5283

1.20

3.87

1.5

1.3

2.3

2.4

g/l

1.49

359

2962

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

926

8249

1.17

3.86

1.6

1.7

1.4

1.3

mmol/l

0.89

800

6853

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

1114

1.40

3.84

2.0

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

1115

1.40

3.82

2.0

1.4

3.5

3.8

g/l

3.77

109

783

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.80

1.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

124

864

1.45

3.80

1.5

1.6

1.2

g/l

0.38

115

816

(3051611) Lipemic interference index of Serum or Plasma

265

1.82

3.77

3.3

3.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.01

3.69

1.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

153

1116

1.39

3.65

2.0

1.4

7.3

7.5

g/l

0.76

113

820

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

232

1.86

3.64

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

145

1050

1.40

3.61

2.0

1.4

3.1

g/l

0.05

109

801

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.66

3.56

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.85

3.52

1.7

1.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.85

3.52

1.0

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

369

1.66

3.52

1.4

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

668

5837

1.18

3.51

4.6

4.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

370

1.66

3.48

1.2

5.1

2.8

u/ml

0.32

118

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.71

3.48

3.5

2.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

120

846

1.43

3.48

1.5

1.6

0.2

g/l

0.34

110

804

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.62

3.47

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

2.15

3.41

1.7

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.99

3.41

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.66

3.39

1.0

1.1

—

(40768443) Skin Pathology biopsy report

161

1201

1.36

3.37

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3030

29538

1.21

3.34

5.4

5.3

2.8

mmol/l

0.01

2767

27053

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

114

2.20

3.34

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.25

3.34

1.1

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.25

3.34

1.1

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

557

1.52

3.33

1.4

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

384

1.63

3.29

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

241

1.79

3.26

2.9

4.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

324

1.68

3.24

1.4

110.4

116.8

u/ml

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.17

3.21

1.1

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.34

3.19

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

5.34

3.19

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.63

3.13

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

366

1.62

3.12

1.3

1.2

3.0

5.6

u/ml

1.33

149

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

282

1.71

3.12

1.7

1.4

30.5

35.7

u/l

0.46

207

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

201

1.85

3.11

1.2

1.1

110.0

191.7

titre

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.69

3.05

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

119

2.11

3.04

1.8

2.1

41.8

42.9

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

300

1.68

3.02

1.8

1.3

—

(40768806) Pleura Pathology biopsy report

147

1.98

2.99

1.8

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

140

1043

1.36

2.99

2.1

1.4

9.4

10.3

g/l

1.86

117

854

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

2.75

2.98

1.8

1.5

13.9

47.2

u/l

0.60

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2964

28892

1.18

2.97

4.9

4.7

mmol/l

0.61

2716

26596

(40761535) Cells panel - Urine sediment

311

2571

1.23

2.97

3.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

334

2782

1.22

2.96

3.3

2.7

0.9

0.7

ug/l

0.79

245

1889

(4062490)

265

1.71

2.92

1.7

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

127

937

1.37

2.89

2.2

1.4

0.6

0.4

g/l

0.42

112

789

(3014271) Vancomycin [Susceptibility]

156

1.93

2.89

4.3

3.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.10

2.88

1.0

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.44

2.87

3.1

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.44

2.87

3.1

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.44

2.87

3.1

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

450

3868

1.19

2.87

4.9

32.9

33.5

0.62

312

2538

(3015171) Extractable nuclear Ab [Units/volume] in Serum

161

1234

1.32

2.86

1.2

1.3

0.2

0.8

u/ml

1.83

121

(3033705) Calcium.ionized [Moles/volume] in Venous blood

352

1.60

2.84

2.7

2.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

109

2.12

2.84

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.19

2.83

2.7

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.19

2.83

2.7

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.19

2.83

2.7

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.19

2.83

2.7

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.06

2.80

1.1

1.3

1.5

1.7

umol/24h

0.39

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

103

2.14

2.80

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2941

28678

1.17

2.79

4.8

4.7

1.5

mmol/l

4.51

2674

26217

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

110

2.10

2.78

1.8

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

565

1.46

2.76

2.9

1.6

mg/l

0.17

503

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

145

1.94

2.74

1.9

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

111

2.08

2.72

1.8

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

614

5440

1.16

2.68

1.3

34.6

iu/ml

0.00

182

1709

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

257

1.68

2.67

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

105

763

1.39

2.65

5.3

4.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

126

1.99

2.65

2.0

1.8

6.5

6.1

nmol/l

0.04

102

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

220

1.74

2.64

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

3.13

2.64

1.6

1.2

5.9

6.1

mmol/l

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

112

824

1.37

2.63

2.0

1.4

0.0

g/l

0.96

103

747

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

104

757

1.39

2.60

2.1

1.4

0.0

g/l

0.00

696

(3000570) Elastase.pancreatic [Mass/mass] in Stool

115

852

1.36

2.59

1.4

299.5

302.0

ug/g

0.04

489

(3000093) Morphology [Interpretation] in Blood Narrative

215

1.73

2.55

1.4

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

7.15

2.55

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

427

1.51

2.54

2.0

1.8

3873.6

2596.3

u/l

0.17

173

(3048929) Epstein Barr virus Ab [Presence] in Serum

543

1.45

2.51

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

356

1.55

2.51

1.2

318.8

276.4

u/ml

0.52

210

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

372

1.54

2.51

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

562

4973

1.16

2.50

5.8

3.9

2.6

2.8

ug/l

0.11

501

4428

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

105

772

1.37

2.49

2.1

1.4

0.0

g/l

0.00

697

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.20

2.47

1.1

1.2

0.7

umol/24h

0.02

(3047189) Immunofixation for 24 hour Urine

2.17

2.40

1.6

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

2.35

2.38

1.2

1.3

107.5

64.7

mu/l

—

(3000330) Specific gravity of Urine by Test strip

195

1573

1.25

2.37

4.4

3.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.26

2.37

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.61

2.35

1.2

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.51

2.35

1.3

1.1

—

(3045414) Leukocytes [Presence] in Urine

172

1371

1.27

2.32

2.1

2.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

339

1.54

2.32

1.7

1.3

—

(1002224) Polysomnography panel

131

1008

1.31

2.32

1.1

—

(3036603) Volume of Urine

169

1.78

2.32

1.4

1923.9

1761.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

268

1.61

2.32

1.7

1.4

0.3

0.4

g/l

0.39

187

(3028192) IgG subclass 2 [Mass/volume] in Serum

268

1.61

2.32

1.7

1.4

2.6

2.8

g/l

0.34

186

(44790047)

245

1.64

2.31

1.6

1.4

—

(44790048)

245

1.64

2.31

1.6

1.4

—

(44806118)

245

1.64

2.31

1.6

1.4

—

(44790049)

245

1.64

2.31

1.6

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

117

887

1.33

2.30

2.0

1.4

37.0

37.6

g/l

0.48

101

736

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

162

1284

1.27

2.29

2.9

2.4

0.6

0.7

0.42

156

1224

(3025468) Yersinia sp identified in Specimen by Organism specific culture

332

1.54

2.29

1.7

1.3

—

(3048879) Bone marrow aspiration report

2.38

2.29

2.0

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

269

1.61

2.29

1.7

1.4

5.9

6.7

g/l

1.23

188

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

471

4142

1.16

2.28

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

622

1.39

2.28

1.5

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

390

1.50

2.26

1.7

1.3

—

(3025315) Body weight

3.89

2.25

6.4

4.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

342

1.53

2.24

1.7

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

232

1.65

2.23

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

335

1.53

2.21

1.7

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.34

2.21

1.4

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

148

1166

1.28

2.21

1.8

1.6

1.5

g/l

0.04

128

989

(3036670) Protein [Mass/volume] in Synovial fluid

2.05

2.21

1.6

1.1

35.8

38.1

g/l

0.39

(40761536) Microorganisms panel - Urine sediment

272

2292

1.20

2.20

5.0

4.1

—

(4306422)

368

1.50

2.20

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

150

1.81

2.20

1.1

1.0

1.1

ratio

—

(4010399)

264

2219

1.21

2.20

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

336

1.53

2.19

1.6

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.24

2.17

1.1

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

289

1.56

2.16

1.6

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

4.29

2.15

7.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

108

1.95

2.15

1.8

2.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.00

2.14

2.6

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2835

27688

1.13

2.13

4.3

4.2

1.3

mmol/l

0.50

2553

25049

(3025941) Bacteria identified in Stool by Culture

188

1532

1.24

2.12

1.4

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

639

1.37

2.12

1.2

1.3

23.3

45.2

u/ml

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

615

1.37

2.09

1.3

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

348

1.50

2.09

1.7

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

332

1.51

2.08

1.7

1.3

—

(1761868) Lipid panel - Serum or Plasma

874

9468

0.90

2.07

3.1

3.0

—

(4211845)

161

1.75

2.05

3.2

3.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.50

2.05

1.0

1.3

—

mmol/l

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

3.50

2.05

1.0

1.2

—

mmol/l

—

(3026389) Candida sp identified in Specimen by Organism specific culture

432

1.44

2.05

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

110

844

1.31

2.03

1.5

1.6

0.1

iu/ml

0.19

182

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

359

1.48

2.02

2.4

39.3

27.8

mg/l

0.54

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.50

2.01

1.0

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

2.01

2.00

1.5

1.4

2.4

3.7

umol/l

1.49

(4024509)

336

1.50

1.99

2.0

1.6

—

(4268621)

248

1.58

1.98

2.5

2.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.36

1.95

2.3

2.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

452

4012

1.15

1.94

4.9

3.8

22.4

24.1

1.75

242

1934

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

113

1.86

1.91

1.9

2.0

16.8

14.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

249

2113

1.19

1.90

1.2

—

(3023419) Bacteria identified in Sputum by Culture

348

1.47

1.89

1.9

2.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.19

1.88

1.0

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.16

1.88

1.4

109.7

108.7

ng/l

0.01

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

206

1720

1.21

1.87

2.6

2.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.09

1.86

1.1

89.5

88.7

—

(3022621) pH of Urine by Test strip

238

2017

1.19

1.85

3.7

3.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

4.17

1.82

1.0

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

3.05

1.80

2.7

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

470

1.39

1.79

3.0

3.4

56.3

57.5

0.33

470

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.34

1.77

1.3

1.7

—

(3006462) Nitrate [Presence] in Urine

146

1.72

1.77

3.0

3.5

—

(3045424) Erythrocytes [Presence] in Urine

489

1.38

1.75

1.9

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

209

1.58

1.73

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

423

1.40

1.72

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

210

1.58

1.70

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

210

1.58

1.70

1.2

—

(3012441) Differential panel - Pleural fluid

179

1.63

1.69

1.7

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

187

1.61

1.69

1.7

1.5

0.8

1.1

promille

0.47

143

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

111

878

1.27

1.68

1.2

1.3

33.3

51.0

u/ml

—

(3003327) Ova and parasites identified in Stool by Light microscopy

112

887

1.27

1.68

1.6

1.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.10

1.65

1.8

2.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

244

1.52

1.65

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

212

1.56

1.65

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

212

1.56

1.65

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

569

5182

1.12

1.64

1.3

7.0

13.3

u/ml

1.92

208

1982

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

229

1.53

1.62

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

213

1.55

1.62

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.57

1.61

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.33

1.60

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

541

1.34

1.59

2.7

2.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.95

1.59

1.1

1.3

115.6

134.6

nmol/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

231

1.52

1.57

3.2

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

248

1.50

1.55

1.4

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.86

1.50

2.7

1.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.95

1.48

1.1

96.0

91.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.12

1.44

1.1

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

212

1.51

1.43

2.2

2.1

—

(3020491) Glucose [Moles/volume] in Blood

204

1.52

1.43

1.2

2.5

7.3

6.7

mmol/l

0.67

132

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

440

1.35

1.40

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

165

1.58

1.40

1.7

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

2.61

1.36

1.2

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.61

1.36

34.8

11.7

4.4

5.3

mmol/l

—

(3019150) Specific gravity of Urine by Refractometry

696

6470

1.09

1.35

4.8

4.5

1.0

kg/l

0.31

127

980

(3007566) Smooth muscle Ab [Titer] in Serum

734

1.26

1.35

1.2

40.0

183.9

titre

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.50

1.30

2.3

1.5

—

(3042631) Mycobacterium sp identified in Specimen

309

1.40

1.30

2.2

3.2

—

(21494755) Public health laboratory ask at order entry panel

161

1886

0.85

1.28

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

153

1.57

1.28

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

169

1.54

1.28

1.7

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

154

1.56

1.25

13.0

12.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.40

1.24

1.8

2.8

—

(4198724)

1.97

1.22

1.5

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.63

1.21

1.0

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

104

854

1.22

1.21

1.3

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

173

2001

0.86

1.20

1.8

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.31

1.18

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.71

1.17

2.4

2.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.16

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

588

1.26

1.16

1.3

192.5

215.3

miu/ml

0.20

277

(42529406) Shigella sp [Presence] in Stool by Culture

104

860

1.22

1.14

1.3

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

537

1.27

1.13

1.7

1.8

0.8

nmol/l

0.00

438

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

103

1.65

1.12

1.1

1499.1

1639.7

miu/ml

0.16

103

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

131

1112

1.19

1.10

1.7

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

719

1.23

1.10

2.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.38

1.09

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

2.38

1.09

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.38

1.09

1.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

102

847

1.21

1.09

1.3

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

235

1.41

1.08

1.2

1.1

—

u/ml

—

(36660697) Celiac disease serology panel - Serum

262

2346

1.13

1.07

1.2

—

(3008898) HLA-B27 [Presence]

104

867

1.21

1.07

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

374

3419

1.11

1.06

1.9

2.1

115.5

127.4

ug/g

0.36

281

2642

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.12

1.05

1.9

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

253

0.63

1.04

1.3

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

681

6399

1.08

1.04

1.3

0.8

1.8

u/ml

5.98

160

1669

(3028308) Erythrocytes [#/volume] in Pleural fluid

187

1.45

1.03

1.4

1.6

6106.3

62598.0

e6/l

0.99

110

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.27

1.03

4.0

6.8

71.6

48.5

ug/min

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

154

1.50

1.03

1.7

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.06

1.02

2.0

2.9

0.3

0.8

u/field

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.84

1.02

1.2

—

36.6

titre

—

(40768441) Liver Pathology biopsy report

138

1.52

1.02

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

106

1.61

1.02

1.1

1.4

—

(44806420)

1.65

1.00

2.7

2.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.18

0.98

1.0

1.3

—

(3017704) Immunofixation for Urine

140

1.50

0.97

2.0

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

140

1.50

0.97

1.7

2.1

0.9

3.7

u/field

1.21

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

2.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

190

1.42

0.96

2.3

2.5

—

(3004775) Volume in Urine collected for unspecified duration

216

1.39

0.95

1.9

2.4

655.7

613.9

0.24

149

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.77

0.94

1.7

2.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

115

1342

0.85

0.94

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

109

1.56

0.93

1.1

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

109

1.56

0.93

1.1

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

217

1.39

0.93

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.72

0.92

2.0

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

269

1.34

0.92

1.4

1.5

—

(3044007) Cell count panel - Peritoneal fluid

1.73

0.92

1.1

2.6

—

(3006653) Thiamine [Moles/volume] in Blood

142

1.48

0.92

1.1

1.3

133.8

135.3

nmol/l

0.08

142

(3035933) Granulocytes/100 leukocytes in Blood

1.82

0.92

1.6

2.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.67

0.91

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.07

0.89

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.07

0.89

1.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.07

0.89

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

377

1.28

0.88

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

290

2647

1.10

0.88

1.6

1.7

1.4

0.01

245

2295

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

246

1.34

0.87

1.9

2.4

1.5

2.4

u/field

0.83

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

238

1.35

0.86

1.0

805.8

712.8

ng/l

0.40

148

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.67

0.85

1.1

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

239

0.67

0.84

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

239

0.67

0.84

1.3

1.4

—

(3016879) Cocaine [Presence] in Urine

434

1.25

0.83

1.9

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

205

1.37

0.83

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

238

0.67

0.83

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

238

0.67

0.83

1.3

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

112

967

1.16

0.82

1.6

1.9

—

(3024928) Oxygen saturation in Venous blood

543

1.22

0.82

3.1

2.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

142

1248

1.14

0.82

1.3

1.5

—

(3016750) Collection duration of Urine

146

1.44

0.82

1.7

2.2

478.1

499.1

min

0.39

117

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.88

0.81

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

105

1.53

0.81

2.1

1.6

0.5

0.4

ug/l

0.22

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.65

0.81

3.2

2.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

213

0.66

0.81

1.4

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

400

1.25

0.81

2.0

1.5

63.4

60.2

0.27

245

(3045788) Cell count panel - Pleural fluid

172

1.40

0.80

1.5

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

241

1.33

0.80

1.0

33.9

47.9

ng/l

1.42

153

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

219

1982

1.11

0.80

1.2

172.4

139.9

iu/ml

0.55

785

(3016650) Hepatitis A virus Ab [Presence] in Serum

374

1.26

0.79

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.73

0.79

1.2

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

666

1.19

0.78

3.7

3.2

0.8

nmol/l

0.84

525

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

123

0.57

0.77

10.1

12.4

1049.1

807.8

nmol/l

—

117

(3027008) Opiates [Presence] in Urine

466

1.23

0.77

1.9

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.77

0.76

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

467

1.22

0.76

1.9

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

148

1314

1.13

0.75

1.3

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

818

1.17

0.74

1.2

1.3

15.1

5.9

u/ml

0.47

141

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

369

1.25

0.74

1.2

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

478

1.22

0.73

1.8

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

210

1.34

0.73

1.4

1.6

1644.7

2299.9

e6/l

0.38

155

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.84

0.73

2.0

1.9

20.0

19.2

umol/l

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

108

1.48

0.73

1.6

2.5

227.3

149.8

umol/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

370

1.25

0.73

2.0

1.6

—

(40762365) Oxygen content in Arterial blood by calculation

2.00

0.72

1.6

1.7

15.5

15.7

ml/dl

—

(3028300) Cannabinoids [Presence] in Urine

470

1.22

0.72

1.9

1.7

—

(3045716) Anion gap in Serum or Plasma

142

1.41

0.72

2.3

2.0

8.5

9.7

mmol/l

1.27

110

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.92

0.70

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

665

1.18

0.70

1.8

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

126

1.43

0.70

1.1

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

284

1.27

0.68

1.1

1.0

2.4

u/ml

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

192

0.68

1.4

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

203

0.69

0.67

1.3

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

136

1.40

0.66

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.79

0.66

1.8

2.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

439

1.21

0.66

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

810

1.15

0.65

1.2

1.3

2.1

6.0

u/ml

—

(3005033) Fetal Nuchal fold Thickness US

202

0.69

0.65

1.3

1.4

—

(3027944) Amphetamines [Presence] in Urine

459

1.20

0.64

1.7

1.6

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.73

0.64

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

129

1.40

0.63

1.1

—

10.1

u/ml

—

(3000492) Spirometry study

274

2544

1.08

0.62

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.67

0.61

1.2

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.50

0.59

1.2

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

236

1.27

0.59

1.0

333.9

353.5

ng/l

0.11

153

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.59

0.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.51

0.58

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

193

1.30

0.57

1.2

—

(40768446) Kidney Pathology biopsy report

1.48

0.57

2.3

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

141

1.35

0.56

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

785

0.86

0.56

1.6

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.46

0.56

1.1

—

(3005570) Glucose [Moles/volume] in Urine

321

1.22

0.54

1.9

2.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

142

1.34

0.54

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

142

1.34

0.54

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

142

1.34

0.54

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

827

1.13

0.52

1.8

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

415

1.18

0.52

1.4

1.6

—

(3011288) Drugs identified in Urine by Screen method

314

1.21

0.51

3.3

2.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

100

1.40

0.51

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.50

0.51

1.0

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

388

1.19

0.51

1.1

1.3

40.9

50.2

u/ml

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

688

1.14

0.50

1.2

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

279

1.22

0.50

1.7

1.4

22.1

33.6

1.21

166

(3029075) Extractable nuclear Ab panel - Serum

1.49

0.49

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

717

1.13

0.49

1.4

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.52

0.48

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

119

1.35

0.48

2.9

1.9

16.5

317.2

ug/l

0.67

108

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

119

1.35

0.48

1.7

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

119

1.35

0.48

1.7

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.47

0.47

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

282

1.21

0.46

1.4

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

418

0.84

0.46

1.4

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1095

0.90

0.45

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

283

1.20

0.45

1.2

61.9

57.7

u/l

0.19

193

(3038177) Helicobacter pylori Ab [Presence] in Serum

450

1.16

0.44

1.4

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

231

0.78

0.44

1.4

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

1.40

0.44

1.7

1.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

195

1819

1.08

0.44

1.3

—

(3020650) Glucose [Presence] in Urine

1.45

0.44

1.2

1.6

—

(3024932) HLA-DR beta [Type]

1.37

0.44

1.3

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

139

1.30

0.43

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.61

0.43

1.2

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.36

0.41

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

277

1.19

0.41

1.1

1.2

339.8

375.0

nmol/l

0.45

234

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.40

0.0

2.8

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.40

0.0

1.4

—

22.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.40

0.0

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

335

1.17

0.38

1.2

1.3

7.5

7.6

mmol/l

0.08

244

(3002523) Influenza virus A Ag [Presence] in Specimen

298

1.18

0.38

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.32

0.37

2.2

1.3

—

(44806071)

1.35

0.37

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

704

0.89

0.37

2.2

2.3

71.1

90.3

ug/min

0.21

410

(3006922) Hepatitis E virus Ab [Presence] in Serum

152

1.25

0.37

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

318

1.17

0.36

1.3

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

343

0.84

0.36

1.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

153

1.24

0.35

1.3

1.2

178.8

284.1

u/l

0.63

139

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

153

1.24

0.35

1.1

1.4

—

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.62

0.35

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

159

1489

1.07

0.35

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

135

1.26

0.35

1.4

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

184

1735

1.06

0.34

1.3

181.9

181.6

u/ml

0.00

168

1598

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

109

1.29

0.33

3.0

4.7

—

(3012516) Albumin [Mass/volume] in Urine

930

9102

1.03

0.32

3.1

3.2

597.3

327.3

mg/l

0.68

564

5402

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

101

1.29

0.31

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.32

0.30

1.1

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

390

1.13

0.30

1.1

0.7

1.2

u/ml

0.45

150

(3050129) First trimester maternal screen panel - Serum or Plasma

272

0.84

0.30

1.3

1.5

—

(3024471) HLA-A [Type]

1.30

0.30

1.0

—

(3011648) Oxygen content in Venous blood

207

0.82

0.30

1.6

2.1

11.5

10.8

0.22

207

(3000034) Microalbumin [Mass/volume] in Urine

287

1.15

0.30

3.3

2.8

17.8

15.7

mg/l

0.09

206

(3003740) Influenza virus B Ag [Presence] in Specimen

297

1.15

0.29

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

1.23

0.29

2.6

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

176

1.19

0.28

1.4

1.5

2.3

8.1

u/l

—

(3009508) Creatinine [Moles/volume] in Urine

961

9428

1.03

0.28

3.1

6.8

mmol/l

0.03

804

7859

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

195

1.18

0.28

1.6

1.5

0.9

1.0

g/l

0.07

195

(3036071) Salmonella sp Ab [Titer] in Serum

1.32

0.28

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

407

0.88

0.28

1.1

13.9

2049.3

iu/ml

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

118

0.76

0.27

1.1

1.8

208.1

199.8

u/l

—

118

(44813793)

196

1.17

0.27

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

179

1.17

0.25

1.3

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

158

0.82

0.23

1.5

1.7

—

(4094501)

824

1.07

0.23

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

976

9608

1.02

0.22

3.8

3.9

7.3

mg/mmol

0.01

591

5743

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

181

1.16

0.22

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.77

0.22

1.4

9.7

8.8

ug/l

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

333

1.11

0.22

1.1

1.8

3.1

u/ml

0.70

164

(3008401) Mugwort IgE Ab [Units/volume] in Serum

324

1.11

0.22

1.1

0.9

0.8

u/ml

0.06

134

(3018133) Calcium [Moles/volume] in Urine

1.19

0.21

2.6

1.7

3.1

mmol/l

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.5

—

3.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

3.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

101

0.79

0.21

1.0

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

117

1.20

0.20

1.0

0.2

1.0

u/ml

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.20

0.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

943

0.94

0.20

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

260

0.88

0.19

2.2

1.7

32.2

21.4

u/ml

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.18

0.19

1.2

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

841

1.06

0.19

1.9

1.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.13

0.18

1.0

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

1.21

0.18

2.9

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

959

0.95

0.18

1.8

1.7

3.5

3.6

mg/l

0.05

697

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.73

0.17

1.0

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

144

1388

1.04

0.15

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

193

0.88

0.15

1.1

1.3

9.6

11.5

mmol/l

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.21

0.15

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.21

0.15

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.21

0.15

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.21

0.15

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

371

1.08

0.15

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

121

1.16

0.15

1.1

—

(4146454)

348

0.92

0.15

2.9

2.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

236

1.10

0.14

1.1

6.6

3.2

u/ml

—

(4015189)

1.19

0.14

5.0

2.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

141

1.14

0.14

1.2

1.1

36.6

21.5

u/l

0.52

(3019977) pH of Arterial blood

142

1.13

0.12

1.4

2.5

7.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

1.18

0.12

2.2

6.7

25.5

25.3

mmol/l

—

(3032773) Endomysium IgG Ab [Titer] in Serum

239

1.09

0.12

1.1

—

(3000012) Reticulocyte production index

143

1.12

0.11

1.8

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

163

1.10

0.10

1.2

88.5

77.2

u/l

0.36

142

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

125

0.88

0.10

1.5

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

161

1573

1.02

0.09

1.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

145

0.90

0.09

1.2

—

(3025130) Human papilloma virus identified in Specimen

370

0.95

0.09

1.4

1.7

—

(3033799) Differential panel - Peritoneal fluid

1.11

0.09

2.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

766

0.97

0.09

2.1

1.6

8956.0

11107.2

e6/l

0.47

549

(4133840)

1.07

0.08

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

298

0.94

0.08

1.8

1.3

22091.2

119018.8

e6/l

1.51

195

(3051101) Glucose [Moles/volume] in Cord blood

0.78

0.08

4.4

6.3

—

(3044941) Cell count panel - Synovial fluid

480

1.04

0.08

1.7

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

382

1.05

0.07

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.07

0.07

1.1

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.07

0.07

1.1

2.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.02

0.07

1.0

1.1

—

(3035880) pH of Pleural fluid

1.12

0.06

1.8

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

640

0.97

0.06

3.1

3.6

31.7

24.1

mg/l

0.51

410

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.86

0.06

1.4

1.5

—

(3004451) EKG impression Narrative

138

1.09

0.06

1.5

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

346

1.04

0.05

1.0

1.1

3.9

3.0

u/ml

0.16

142

(3028679) Herpes simplex virus Ab [Presence] in Serum

110

1.09

0.05

1.3

1.2

—

(4034850)

103

1049

0.98

0.05

8.3

9.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

773

1.02

0.05

1.0

1.1

2.6

7.0

u/ml

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

302

3047

0.99

0.04

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

258

1.05

0.04

1.0

1.1

9.8

2.5

u/ml

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

140

0.93

0.04

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

150

0.93

0.04

1.4

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

447

1.03

0.04

1.1

1.2

29.5

23.9

u/l

0.24

386

(3001019) Free T4 and TSH panel - Serum or Plasma

127

1287

0.99

0.04

2.1

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

402

0.97

0.04

1.4

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

505

5026

1.01

0.03

1.4

—

(3021788) Differential panel - Synovial fluid

559

1.02

0.03

2.1

1.4

—

(3022689) Creatine [Moles/volume] in Urine

1.06

0.01

1.1

1.4

—

(3017569) Oxygen content in Arterial blood

134

1.04

0.00

1.6

2.1

—

(3024263) Appearance of Synovial fluid

154

1.04

0.00

2.1

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

151

0.99

0.00

1.0

—

(3015183) Erythrocyte sedimentation rate

104

0.96

0.00

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

0.89

0.00

1.8

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.89

0.00

1.2

1.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.01

0.00

3.2

1.8

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.90

0.00

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

2.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.98

0.00

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

0.94

0.00

1.2

1.3

64.8

48.6

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.9

—

1.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3002619) Bacteria identified in Specimen by Culture

0.94

0.00

1.2

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.6

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

2.4

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.6

—

2.4

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.1

—

328.9

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3034426) Prothrombin time (PT)

0.92

0.00

1.6

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_MENINGES_CEREBRAL_EXALLC – Benign neoplasm: Cerebral meninges

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign neoplasm: Cerebral meninges

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints